Restless Legs Syndrome Quiz

Restless Legs Syndrome (RLS): Practice Guide for Exam-Style Questions

Understanding Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disease, requires mastering its unique diagnostic criteria, pathophysiology, and management strategies. This guide breaks down the essential concepts to help you tackle related questions with confidence.

Defining the Core Symptoms (URGE Criteria)

The diagnosis of RLS is clinical and relies on meeting four essential criteria. A helpful mnemonic is URGE. Exam questions often test these specific components.

• U – Urge to move the legs, usually but not always accompanied by or caused by uncomfortable and unpleasant sensations in the legs.
• R – Rest induced: The urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity such as lying or sitting.
• G – Gets better with activity: Symptoms are partially or totally relieved by movement, such as walking or stretching, at least as long as the activity continues.
• E – Evening or nighttime worsening: Symptoms are worse in the evening or night than during the day or only occur in the evening or night.

Primary vs. Secondary RLS: Key Distinctions

It’s crucial to differentiate between primary (idiopathic) and secondary RLS. Primary RLS has no known underlying cause and often has a genetic component. Secondary RLS is caused by another medical condition or factor. Identifying the cause is key to management.

The Dopamine and Iron Connection

The leading hypothesis for RLS pathophysiology involves dopamine dysregulation in the central nervous system. Iron is a critical cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis. Low brain iron, even with normal peripheral iron stores, is strongly implicated.

Common Triggers and Exacerbating Factors

Questions may present a patient with worsening symptoms. Recognizing potential triggers is a high-yield topic. Common culprits include caffeine, alcohol, nicotine, and certain medications like antihistamines, some antidepressants (SSRIs), and antiemetics.

Non-Pharmacological Management Strategies

Lifestyle modifications are the first-line treatment for mild RLS and an important adjunct for moderate to severe cases. These interventions are often tested as the “best initial step” in management.

• Establishing good sleep hygiene (regular sleep schedule).
• Engaging in moderate, regular exercise (avoiding intense exercise near bedtime).
• Avoiding known triggers such as caffeine and alcohol in the evening.
• Leg massage, hot baths, or applying heating pads or cold packs.
• Engaging in mentally alerting activities during periods of rest (e.g., puzzles, video games).

First-Line Pharmacological Treatments

For persistent, moderate-to-severe RLS, pharmacological intervention is necessary. First-line agents have shifted over time. Currently, alpha-2-delta calcium channel ligands like gabapentin or pregabalin are often preferred due to a lower risk of augmentation compared to dopamine agonists.

Understanding Augmentation: A Critical Side Effect

Augmentation is a serious complication of long-term dopaminergic therapy. It involves a paradoxical worsening of RLS symptoms: they appear earlier in the day, become more intense, spread to other body parts (like the arms), and respond more briefly to medication. Recognizing this is key to adjusting treatment.

Differential Diagnosis: What to Rule Out

RLS can be mimicked by other conditions. A differential diagnosis question might ask you to distinguish it from peripheral neuropathy, leg cramps, positional discomfort, or akathisia (a movement disorder characterized by a feeling of inner restlessness and an inability to stay still).

Key Takeaways

• Diagnosis is clinical, based on the four essential “URGE” criteria.
• Pathophysiology is linked to CNS dopamine dysfunction and low brain iron.
• Always check serum ferritin and consider iron supplementation if levels are low.
• Lifestyle changes are the initial management step for mild symptoms.
• Alpha-2-delta ligands (gabapentin, pregabalin) are often preferred first-line agents over dopamine agonists to avoid augmentation.

This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition.